healthcare
healthcare Articles
Genome editing company LogicBio Therapeutics expects to price more than 5 million shares for an initial public offering valued up to almost $93 million.
Published:
Last Updated:
Proteostasis Therapeutics shares absolutely exploded on Thursday after the company announced positive preliminary results from its early-stage cystic fibrosis trial.
Published:
Last Updated:
Endocyte shares were up sharply early Thursday after it was announced that the company would be acquired.
Published:
Last Updated:
Synthetic biology company Twist Bioscience expects to price 5 million shares for an initial public offering valued up to more than $103 million.
Published:
Last Updated:
Merck shares were up handily on Tuesday after the company announced a key update from the FDA on its Lynparza for the treatment of pancreatic cancer.
Published:
Last Updated:
UnitedHealth released better-than-expected third-quarter financial results before the markets opened on Tuesday.
Published:
Last Updated:
Johnson & Johnson reported better-than-expected third-quarter financial results before the markets opened on Thursday.
Published:
Last Updated:
UnitedHealth is scheduled to report its second-quarter financial results before the markets open on Tuesday.
Published:
Last Updated:
Johnson & Johnson is scheduled to report its third-quarter financial results early Tuesday, and analysts expect solid growth on the top and bottom lines.
Published:
Last Updated:
Tetraphase Pharmaceuticals shares were up handily on Friday after the company announced the U.S. commercial launch of Xerava (eravacycline) for the treatment of complicated intra-abdominal infections.
Published:
Last Updated:
Corium shares jumped on Friday after the company announced that it entered into a definitive merger agreement under which Gurnet Point Capital will acquire Corium.
Published:
Last Updated:
Compugen shares pushed higher on Thursday after it was announced that Bristol-Myers Squibb will make a $12 million equity investment as part of its collaboration on a cancer trial.
Published:
Last Updated:
CRISPR Therapeutics shares made a handy gain on Thursday after the company announced a key FDA decision concerning its collaboration with Vertex Pharmaceuticals.
Published:
Last Updated:
Ionis Pharmaceuticals shares were relatively flat on Wednesday after the company announced a new collaboration with Roche to develop IONIS-FB-LRx for the treatment of complement-mediated diseases.
Published:
Last Updated:
AcelRx shares made a solid gain on Wednesday despite a less-than-favorable update from the FDA. However, there is a vote for approval on Friday. and that seems to be what investors are optimistic...
Published:
Last Updated: